No record found
No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Shifa International Hospitals Limited was incorporated in Pakistan on September 29, 1987 as a private limited company under the repealed Companies Ordinance, 1984 and converted into a public limited company on October 12, 1989. The principal activity of the Company is to establish and run medical centers and hospitals in Pakistan. The Company is also running medical centers, pharmacies and Lab collection points in different cities of Pakistan.
| Dr. Zeeshan Bin Ishtiaque | CEO |
| Dr. Habib ur Rahman | Chairperson |
| Muhammad Naeem | Company Secretary |
M/s Corplink (Private) Limited, Wings Arcade, 1-K, Commercial, Model Town, Lahore
BDO Ebrahim & Co. Chartered Accountants
June
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Oct 29, 2026 | Transmission of Quarterly Report for the Period Ended 30-09-2026 | View PDF |
| Oct 26, 2026 | Financial Results for the 1st Quarter Ended September 30, 2026 | View PDF |
| Oct 2, 2026 | Transmission of Annual Report for the Year Ended 30-06-2026 | View PDF |
| Sep 14, 2026 | Financial Results for the Year Ended 30-06-2026 | View PDF |
| Apr 30, 2026 | Transmission of Quarterly Report for the Period Ended March 31, 2026 | View PDF |
| Date | Title | Document |
|---|---|---|
| Oct 26, 2026 | Certified Copy of Resolutions passed by the Shareholders in the 40th Annual General Meeting of Shifa International Hospitals Limited Held on October 24, 2026 | View PDF |
| Oct 15, 2026 | Board Meeting | View PDF |
| Oct 5, 2026 | Notice of Annual General Meeting - Newspaper Clippings | View PDF |
| Oct 2, 2026 | Notice of 40th Annual General Meeting 2026 | View PDF |
| Sep 3, 2026 | Board Meeting | View PDF |
| Date | Title | Document |
|---|---|---|
| Nov 11, 2026 | Material Information | View PDF |
| Nov 6, 2026 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
| Nov 5, 2026 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
| Nov 5, 2026 | Credit of Final Cash Dividend (D-28) | View PDF |
| Oct 30, 2026 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View |
Financials
All numbers in thousands (000's) except EPS
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Sales | 30,283,833 | 27,967,661 | 23,563,840 | 19,721,425 |
| Profit after Taxation | 2,792,549 | 2,328,980 | 1,362,074 | 1,181,406 |
| Q1 2027 | Q3 2026 | Q2 2026 | Q1 2026 | |
|---|---|---|---|---|
| Sales | 8,642,280 | 7,295,690 | 7,771,133 | 7,615,508 |
| Profit after Taxation | 804,497 | 591,484 | 874,253 | 743,577 |

Ratios
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 100.00 | 100.00 | 100.00 | 100.00 |
| Net Profit Margin (%) | 9.22 | 8.33 | 5.78 | 5.99 |
| EPS Growth (%) | 19.76 | 70.95 | 15.30 | 1.63 |
| PEG | 0.58 | 0.18 | 0.44 | 4.02 |








Feedback
Terms of Use
https://www.psx.com.pk